NCT00621491View on ClinicalTrials.gov

Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation

NACompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

July 31, 2008

Conditions

Cardiac PacingComplicationsVenous Thrombosis

Interventions

DRUG

Warfarin

Single daily dose of Warfarin (5 mg/orally), adjusted to achieve an International Normalized Ratio (INR) between 2 to 3.5 times the normal value during six months

Trial Locations (1)

05403-900

Heart Institute (InCor) - Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT00621491 - Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation | Biotech Hunter | Biotech Hunter